Cost-Effectiveness Analysis of Ibrutinib For Waldenström Macroglobulinemia In Italy
Nov 1, 2016, 00:00 AM
10.1016/j.jval.2016.09.1384
https://www.valueinhealthjournal.com/article/S1098-3015(16)32750-4/fulltext
Section Title :
Disease-Specific Studies
Section Order :
1300
First Page :
A587
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)32750-4&doi=10.1016/j.jval.2016.09.1384